SmartCells' SmartInsulin is a once-daily subcutaneous injectable formulation of insulin for the treatment of type 1 and type 2 diabetes. SmartInsulin comprises insulin molecules conjugated to a biocompatible and biodegradable polymer, which binds to a multivalent glucose-binding molecule. Once injected, it self-assembles to form an insoluble matrix. Insulin is released from the system only when the therapeutic is unbound by the presence of a specific glucose concentration.
Suite 419E
100 Cummings Center
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
Psychedelics appear to be in vogue after years of being relegated to alternative medicine. But investor pushback after the highly anticipated release of Phase III trial data by Compass Pathways reveals an increasingly high bar for development.
Emerging Company Profile: Early-stage biotech Eolo will seek cash and deals for its novel obesity drug SANA after positive Phase I results for weight loss, lean muscle mass preservation and fat mass reduction.